Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice

by Ottaiano, Alessandro, Capozzi, Monica, Tafuto, Salvatore, De Stefano, Alfonso, De Divitiis, Chiara, Romano, Carmela, Avallone, Antonio, Nasti, Guglielmo
Published in Front Oncol (2019)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis

by Ottaiano, Alessandro, De Stefano, Alfonso, Capozzi, Monica, Nappi, Anna, De Divitiis, Chiara, Romano, Carmela, Silvestro, Lucrezia, Cassata, Antonino, Casaretti, Rossana, Tafuto, Salvatore, Caraglia, Michele, Berretta, Massimiliano, Nasti, Guglielmo, Avallone, Antonio
Published in Front Pharmacol (2018)

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

by Ottaiano, Alessandro, Scotti, Valerio, De Divitiis, Chiara, Capozzi, Monica, Romano, Carmen, Cassata, Antonino, Casaretti, Rossana, Silvestro, Lucrezia, Nappi, Anna, Vicario, Valeria, De Stefano, Alfonso, Tafuto, Salvatore, Berretta, Massimiliano, Nasti, Guglielmo, Avallone, Antonio
Published in Oncotarget (2018)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

by Ottaiano, Alessandro, Scala, Stefania, Normanno, Nicola, Napolitano, Maria, Capozzi, Monica, Rachiglio, Anna Maria, Roma, Cristin, Trotta, Anna Maria, D’Alterio, Crescenzo, Portella, Luigi, Romano, Carmela, Cassata, Antonino, Casaretti, Rossana, Silvestro, Lucrezia, Nappi, Anna, Tafuto, Salvatore, Avallone, Antonio, De Stefano, Alfonso, Tamburini, Mario, Picone, Carmine, Petrillo, Antonella, Izzo, Francesco, Palaia, Raffaele, Albino, Vittorio, Amore, Alfonso, Belli, Andrea, Pace, Ugo, Di Marzo, Massimiliano, Chiodini, Paolo, Botti, Gerardo, De Feo, Gianfranco, Delrio, Paolo, Nasti, Guglielmo
Published in BMC Cancer (2019)